Insight Lifetech
Insight Lifetech is a Shenzhen-based medical technology company developing and commercializing interventional cardiovascular devices — including FFR pressure systems, 60MHz IVUS imaging, microcatheters, and nanosecond PFA ablation systems — serving interventional cardiologists and hospitals in 64 countries.
- Company typePublic
- Founded2015
- HeadquartersShenzhen, China
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Insight Lifetech does
Insight Lifetech Co., Ltd. is a Shenzhen-headquartered medical technology company founded in December 2015 by Dr. Song Liang (Leo Song) that develops, manufactures, and commercializes interventional cardiovascular devices for the precision diagnosis and treatment of coronary artery disease and cardiac arrhythmias. Its product portfolio spans eleven marketed devices organized around four technology platforms: Fractional Flow Reserve (FFR) pressure-measurement systems based on proprietary CathMEMS sensor technology; 60MHz high-definition Intravascular Ultrasound (IVUS) imaging systems (TRUEVISION catheter and VivoHeart console); a family of microcatheters and guide-extension catheters for complex percutaneous coronary intervention (PCI); and nanosecond Pulsed Field Ablation (LotosPFA) systems for cardiac electrophysiology. The company serves interventional cardiologists, cardiac catheterization laboratories, and hospitals performing PCI and atrial fibrillation ablation procedures, with products available in 64 countries and used at over 2,000 medical centers that have collectively treated more than 350,000 patients.
The business model is anchored on the sale of capital equipment (FFR and IVUS consoles) combined with high-margin recurring consumables (pressure microcatheters, IVUS imaging catheters, ablation catheters, and guide-extension catheters), supplemented by professional training, clinical education, and KOL-engagement services delivered through the True North Academy, INSIGHT FORUM, and the CCI Innovation Engineering Center partnership. Distribution combines direct hospital sales in China with international channels supported by NMPA and CE MDR regulatory approvals, alongside medical-education and clinical-trial-driven demand generation. Following its February 2026 listing on the Shanghai Stock Exchange STAR Market (SSE: 688712), in which it raised approximately $143 million at a market capitalization of CNY 20.98 billion, Insight Lifetech operates as a publicly traded commercial-stage medtech company with primary manufacturing in Shenzhen's Pingshan District and R&D collaboration in Shanghai, backed historically by Qiming Venture Partners and other growth investors.
Insight Lifetech firmographics
Firmographics- Name
- Insight Lifetech
- Legal name
- Insight Lifetech Co., Ltd.
- Website
- https://insight-med.com
- Company type
- Public
- Founded year
- 2015
- Operating status
- Ipo
- Headcount range
- 251–500 employees
- Short description
- Insight Lifetech is a Shenzhen-based medical technology company developing and commercializing interventional cardiovascular devices — including FFR pressure systems, 60MHz IVUS imaging, microcatheters, and nanosecond PFA ablation systems — serving interventional cardiologists and hospitals in 64 countries.
- Ownership category
- akta.pro rank
Insight Lifetech industry classification
Industry- Product category
- Interventional Cardiovascular Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industries
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD), Interventional Cardiology (PCI/Structural Heart) (HLAKABAB)
Keywords
Where Insight Lifetech is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
Insight Lifetech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Sales: Sale of cardiovascular intervention medical devices including FFR systems, IVUS systems, microcatheters, and PFA ablation systems. Revenue is generated through capital equipment sales (consoles) and associated consumables (catheters, disposables).
- Professional Services: Clinical training, education programs, and professional support services provided to healthcare professionals through True North Academy and Innovation Center programs.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Insight Lifetech product offering
Product offeringCore offering
Insight Lifetech develops, manufactures, and commercializes interventional cardiovascular medical devices for precision diagnosis and treatment of coronary artery disease and cardiac arrhythmias. Its core offerings span FFR (Fractional Flow Reserve) pressure measurement systems, IVUS (Intravascular Ultrasound) imaging systems, microcatheters for complex PCI, and pulsed field ablation catheters for electrophysiology, sold to hospitals, catheterization labs, and interventional cardiologists across China and international markets.
Differentiator
Problem solved
Functional benefit
Brands
- TruePhysio: Rapid Exchange Pressure Microcatheter product line for FFR measurement
- VivoCardio
- TRUEVISION
- VivoHeart
- TrueCross
- TrueReach
- TrueExtensio
- LotosPFA
- inSmartVision
- True North
- Insight Care
Products and services
- TruePhysio Rapid Exchange Pressure Microcatheter Rapid-exchange pressure microcatheter using proprietary CathMEMS sensor technology with a 0.0205-inch ultra-small profile, compatible with any 0.014-inch guidewire, designed for accurate Fractional Flow Reserve (FFR) measurement during coronary interventions.
- VivoCardio Cardiovascular Pressure Measurement (CPM) System FFR/cRR console for physiological assessment of coronary lesions, enabling adenosine-free FFR measurement via proprietary cRR (constant Resistance Ratio) technology, used by interventional cardiologists in catheterization labs.
- TRUEVISION HD Imaging Catheter High-definition 60MHz Intravascular Ultrasound (IVUS) imaging catheter with 100 FPS imaging for intravascular visualization during complex percutaneous coronary interventions.
- VivoHeart IVUS Console Intravascular Ultrasound (IVUS) console supporting 60MHz high-definition imaging with 10mm/s pullback speed, used by interventional cardiologists for intravascular imaging during PCI procedures.
- TrueCross Microcatheter Single-lumen microcatheter for complex percutaneous coronary interventions, featuring an ultra-thin 1.9F profile designed for crossability and torqueability.
- TrueReach Dual-Lumen Microcatheter Dual-lumen microcatheter designed for complex percutaneous coronary interventions where two independent lumens are required.
- TrueExtensio Guide Extension Catheter Guide extension catheter used during percutaneous coronary interventions to provide backup support and facilitate device delivery in complex procedures.
- LotosPFA Pulsed Field Ablation Catheter Pulsed Field Ablation catheter using proprietary nanosecond PFA (nsPFA) biphasic pulsed field ablation technology with high-density electrode design and single-shot non-rotational ablation approach for cardiac electrophysiology ablation procedures.
- TrueVision 18 Peripheral IVUS Catheter Peripheral Intravascular Ultrasound catheter providing high-definition, high-speed imaging of peripheral vasculature, the first domestically-developed peripheral IVUS product in China.
- TruePhysio X Wireless Pressure Microcatheter Wireless pressure microcatheter enabling full coronary functional assessment as part of an integrated solution, representing the first domestically-developed wireless FFR microcatheter in China.
- iFlowX Intelligent Digital Pressure Pump Intelligent digital balloon inflation device designed for digital and intelligent pressure pump functionality during interventional procedures.
- New Generation Functional Imaging Integrated Solution Next-generation integrated functional imaging solution combining physiological assessment and intravascular imaging capabilities for coronary precision intervention.
- inSmartVision Intelligent Image Analysis Platform Intelligent image analysis software platform for IVUS, providing automated analysis and interpretation of intravascular ultrasound images to support interventional cardiologists.
Quantifiable outcome
- Intravascular imaging-guided complex PCI reduces all-cause mortality by 25%, stent thrombosis by 50%, and unnecessary stent implantation by 23%
- +2 more outcomes
Companies that use Insight Lifetech
Customer profileSegments3 records
Ideal customer profiles2 records
Insight Lifetech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Insight Lifetech partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Prof. Yumei Xue / Guangdong Provincial People's HospitalcoreClinical partnership led by Prof. Yumei Xue's team at Guangdong Provincial People's Hospital for the InsightPFA trial, the world's first nanosecond PFA RCT. The study involved 13 Chinese centers and demonstrated non-inferior efficacy of nsPFA vs RFA.
- JACC (Journal of the American College of Cardiology)minorPublication partner for the InsightPFA study, the world's first nanosecond PFA randomized controlled trial, published in JACC - one of the most influential cardiovascular journals.
- INSIGHTFUL-FFR Clinical Trial PartnerscoreInternational multi-center clinical trial led by Prof. Emanuele Barbato (EAPCI Chairman) at Belgium OLV Hospital and Prof. Junbo Ge at Shanghai Zhongshan Hospital, with participation from ~40 centers across Europe and Asia. FFR inventor Prof. Bernard De Bruyne serves as steering committee chair.
- CCI (Center for Cardiovascular Innovations)coreStrategic partnership with CCI, a non-profit non-governmental academic organization for cardiologists initiated by the Engineering Research Center for Cardiovascular Interventional Technology and Devices of the Ministry of Education (China). The partnership involves joint research projects in cardiovascular imaging and physiology at the CCI Innovation Engineering Center and Animal Study Center.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Insight Lifetech competitors and assessment
Company assessmentBroad incumbents
- Philips (Volcano): Philips Volcano is the global market leader in FFR (pressure guidewires) and IVUS imaging. It is a direct incumbent in Insight Lifetech's core hemodynamic and intravascular imaging categories, with established guideline endorsements and bundled capital-plus-consumables contracts.
- Abbott: Abbott's Vascular division offers PressureWire FFR systems and OPTIS IVUS/OCT imaging, plus structural heart and coronary intervention franchises. It is a direct competitor to Insight Lifetech in FFR/IVUS and shares the same interventional cardiology customer base.
- Boston Scientific: Boston Scientific markets OptiCross IVUS catheters, AVVIGO guidance systems, and the FARAPULSE PFA system in EP. It is a direct competitor in IVUS imaging and an emerging competitor in Insight Lifetech's LotosPFA / nsPFA ablation category.
- Medtronic: Medtronic offers PulseSelect PFA, Arctic Front cryoablation, and a broad cardiac rhythm management portfolio. It is a key competitor in the cardiac electrophysiology and PFA categories where Insight Lifetech is launching LotosPFA.
Direct peers
- ACIST Medical Systems: ACIST (a Bracco company) develops FFR measurement systems and contrast injection devices used in cath labs. It directly overlaps with Insight Lifetech's VivoCardio FFR platform in hemodynamic assessment of coronary lesions.
- Opsens: Opsens offers the OptoWire, an optical FFR pressure guidewire, and is developing structural heart and FFR products. It competes head-to-head with Insight Lifetech's MEMS-based TruePhysio microcatheter and VivoCardio FFR system.
- MicroPort Scientific: MicroPort is a Shanghai-listed interventional cardiology and orthopedics medtech with coronary stents, balloon catheters, and structural heart devices. It is a direct Chinese peer targeting the same interventional cardiology customers as Insight Lifetech.
Emerging players
- CathWorks: CathWorks offers FFRangio, a non-invasive wire-free FFR computation from angiography. It addresses the same physician need as Insight Lifetech's FFR systems (coronary lesion physiology) via a fundamentally different, software-driven approach.
- HeartFlow: HeartFlow provides FFR-CT, a non-invasive coronary physiology assessment derived from CT angiography. It is an alternative to invasive FFR systems like Insight Lifetech's, competing for the same clinical decision point in stable coronary disease.
Regional players
- Lifetech Scientific: Lifetech Scientific (Shenzhen) is a Chinese cardiovascular device company focused on congenital heart disease occluders and peripheral vascular devices. It is a Shenzhen-based regional peer in the broader Chinese interventional cardiovascular device market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Insight Lifetech social profiles
Digital presenceInsight Lifetech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Insight Lifetech leadership team
Management profileNumber of profiles
Profiles1 record
Insight Lifetech subsidiaries and ownership
Company hierarchySubsidiaries2 records
Insight Lifetech funding detail
Funding detailFunding overview
Funding rounds7 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Insight Lifetech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Insight Lifetech
What does Insight Lifetech do?
Insight Lifetech develops, manufactures, and commercializes interventional cardiovascular medical devices for precision diagnosis and treatment of coronary artery disease and cardiac arrhythmias. Its core offerings span FFR (Fractional Flow Reserve) pressure measurement systems, IVUS (Intravascular Ultrasound) imaging systems, microcatheters for complex PCI, and pulsed field ablation catheters for electrophysiology, sold to hospitals, catheterization labs, and interventional cardiologists across China and international markets.
Is Insight Lifetech a public or private company?
Insight Lifetech is a public company. It is classified as public and is currently ipo.
When was Insight Lifetech founded?
Insight Lifetech was founded in 2015. It employs 251 to 500 people.
Where is Insight Lifetech based?
Insight Lifetech is headquartered in Shenzhen, China, in the Asia region.
How does Insight Lifetech make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are professional Services.
Who are Insight Lifetech's main competitors?
Broad incumbents on record are Philips (Volcano), Abbott, Boston Scientific and Medtronic. Direct peers are ACIST Medical Systems, Opsens and MicroPort Scientific. Emerging players are CathWorks and HeartFlow. Lifetech Scientific is listed as a regional player.
Does Insight Lifetech have an API?
No public API is recorded for Insight Lifetech.
What industry is Insight Lifetech in?
Insight Lifetech's product category is Interventional Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLAHAFAD, Electrophysiology Mapping & Ablation Systems. Its NAICS code is 334510 and its SIC code is 3845.